U

UCB Pharma

Biopharmaceuticals for neurology and immunology therapies

Global Alzheimer’s Disease Marketing Lead

Product MarketingUpdated on Nov 14
Full-time$184k - $242k

About the Job

Requirements

  • A bachelor's degree is required.
  • At least 10 years of pharmaceutical strategy, marketing, or commercialization experience is required.
  • At least 2 years of direct Alzheimer’s disease or dementia experience is required.
  • At least 2 years of experience supporting a development-stage, post-proof-of-concept, or pre-launch asset is required.

Responsibilities

  • Build UCB's Alzheimer’s disease knowledge and translate patient, caregiver, stakeholder, diagnostic, access, and competitive insights into asset choices.
  • Lead the global cross-functional forum for learning, collaboration, and commercial decision-making.
  • Develop the patient population and indication vision, value proposition, positioning, and commercialization strategy.
  • Define market-development priorities to support future adoption, including diagnosis, biomarkers, referral and treatment pathways, healthcare infrastructure, and care delivery.
  • Develop market assessments, forecasts, business cases, and commercialization scenarios, including key assumptions, uncertainties, and capability needs.
  • Support evaluation of development and partnering scenarios through commercial assessment of strategic options, assumptions, opportunities, and risks.
  • Bring external stakeholder perspectives into asset decisions and translate the work into clear recommendations for the Asset team.

Desired Qualifications

  • Experience developing market assessments, forecasts, scenarios, or business cases.
  • Strong understanding of Alzheimer’s diagnosis, biomarkers, stakeholders, and treatment pathways.
  • U.S. pharmaceutical commercialization experience.
  • Global pharmaceutical strategy or commercialization experience.
  • Experience supporting partnered or co-development assets.
  • Strong business judgment and ability to synthesize incomplete information.
  • Demonstrated success leading through influence across functions and geographies.

About the Company

UCB Pharma

Biopharmaceuticals for neurology and immunology therapies

UCB Pharma focuses on developing treatments for severe diseases in neurology and immunology. It discovers, develops, and commercializes novel molecules and generates products aimed at improving patient lives. The company works by researching and developing therapies, integrating patient insights to guide innovation, and investing over a quarter of revenue into scientific research. Its global presence (about 9,000 employees across 40 countries) and €5.3 billion 2023 revenue reflect its scale and commitment to bringing therapies to patients worldwide. UCB differentiates itself by combining direct patient engagement with substantial R&D investment to address unmet needs in neurology and immunology, aiming to transform lives through science and patient care.

Company size
10,001+
Company stage
IPO
Headquarters
City of Brussels, Belgium
Founded
1928

Recently Posted Jobs

Explore more opportunities at UCB Pharma

See more jobs